Consistent with higher SCD protein levels in inhibitor-sensitive GBM lines (Fig. 1, G, L, and M), SCD mRNA was generally higher in these lines relative to inhibitor-resistant lines (Fig. 3I). This evidence concerns the gene SCD and glioblastoma.